674347-63-8Relevant academic research and scientific papers
CYCLIC COMPOUNDS AND METHODS OF USING SAME
-
, (2021/07/02)
The present application relates to compounds of Formula (I), as defined herein, and pharmaceutically acceptable salts thereof which are MALT1 inhibitors. The present application also describes pharmaceutical composition comprising a compound of Formula (I), and pharmaceutically acceptable salts thereof, and methods of using the compounds and compositions for treating diseases, such as cancer, autoimmune disorders, and inflammatory disorders.
Facile access to 3-alkyl-substituted 3-hydroperoxy-2,4-pyrrolidinediones using manganese(III)-catalyzed aerobic oxidation
Haque, M. Aminul,Nishino, Hiroshi
experimental part, p. 608 - 619 (2011/12/04)
3-Alkyl-substituted 2,4-pyrrolidinediones were directly oxidized under very mild manganese(III)-catalyzed aerobic oxidation conditions to give the corresponding 3-hydroperoxy-2,4-pyrrolidinediones in quantitative yields. The scope and limitations for the
Catalytic addition of metallo-aldehyde enolates to ketones: A new C-C bond-forming hydrogenation
Koech, Phillip K.,Krische, Michael J.
, p. 691 - 694 (2007/10/03)
The first catalytic cross-aldolization of metallo-aldehyde enolates with ketone acceptors is enabled via hydrogenation of keto-enals with cationic rhodium catalysts. These results, in conjunction with prior studies involving the catalytic hydrogen-mediate
